216 related articles for article (PubMed ID: 22665165)
1. Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.
Li F; Patterson AD; Krausz KW; Tanaka N; Gonzalez FJ
J Lipid Res; 2012 Aug; 53(8):1625-35. PubMed ID: 22665165
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
[TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.
Liu A; Krausz KW; Fang ZZ; Brocker C; Qu A; Gonzalez FJ
Arch Toxicol; 2014 Apr; 88(4):983-96. PubMed ID: 24385052
[TBL] [Abstract][Full Text] [Related]
4. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
Li HH; Tyburski JB; Wang YW; Strawn S; Moon BH; Kallakury BV; Gonzalez FJ; Fornace AJ
Alcohol Clin Exp Res; 2014 Jun; 38(6):1520-31. PubMed ID: 24773203
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.
Cho JY; Matsubara T; Kang DW; Ahn SH; Krausz KW; Idle JR; Luecke H; Gonzalez FJ
J Lipid Res; 2010 May; 51(5):1063-74. PubMed ID: 19965603
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation.
Zhen Y; Krausz KW; Chen C; Idle JR; Gonzalez FJ
Mol Endocrinol; 2007 Sep; 21(9):2136-51. PubMed ID: 17550978
[TBL] [Abstract][Full Text] [Related]
7. Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity.
Luo M; Tan Z; Dai M; Song D; Lin J; Xie M; Yang J; Sun L; Wei D; Zhao J; Gonzalez FJ; Liu A
Arch Toxicol; 2017 Feb; 91(2):897-907. PubMed ID: 27344344
[TBL] [Abstract][Full Text] [Related]
8. Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis.
Wang T; Shah YM; Matsubara T; Zhen Y; Tanabe T; Nagano T; Fotso S; Krausz KW; Zabriskie TM; Idle JR; Gonzalez FJ
J Biol Chem; 2010 Mar; 285(10):7670-85. PubMed ID: 20032461
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
10. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR alpha activation favors the formation of unconjugated bile acids.
Solaas K; Kase BF; Pham V; Bamberg K; Hunt MC; Alexson SE
J Lipid Res; 2004 Jun; 45(6):1051-60. PubMed ID: 15026425
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.
Chen C; Krausz KW; Shah YM; Idle JR; Gonzalez FJ
Chem Res Toxicol; 2009 Apr; 22(4):699-707. PubMed ID: 19256530
[TBL] [Abstract][Full Text] [Related]
14. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
Tanaka N; Matsubara T; Krausz KW; Patterson AD; Gonzalez FJ
Hepatology; 2012 Jul; 56(1):118-29. PubMed ID: 22290395
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum.
Fang ZZ; Krausz KW; Tanaka N; Li F; Qu A; Idle JR; Gonzalez FJ
Arch Toxicol; 2013 Nov; 87(11):1975-1987. PubMed ID: 23575800
[TBL] [Abstract][Full Text] [Related]
16. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
17. Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate.
Dai M; Hua H; Lin H; Xu G; Hu X; Li F; Gonzalez FJ; Liu A; Yang J
J Proteome Res; 2018 Apr; 17(4):1500-1508. PubMed ID: 29498526
[TBL] [Abstract][Full Text] [Related]
18. Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Appl Pharmacol; 2018 Jan; 338():112-123. PubMed ID: 29175453
[TBL] [Abstract][Full Text] [Related]
19. Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation.
Patterson AD; Slanar O; Krausz KW; Li F; Höfer CC; Perlík F; Gonzalez FJ; Idle JR
J Proteome Res; 2009 Sep; 8(9):4293-300. PubMed ID: 19569716
[TBL] [Abstract][Full Text] [Related]
20. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
